Search research articles
Contact Us
Filters
Showing results (181-190 of 286) with videos related to
Page
of 29
Sort By:
Blood
|
May 28, 2009
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
Ellen Leich, Itziar Salaverria, Silvia Bea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
David W Scott, Anja Mottok, Daisuke Ennishi, et al.
Blood
|
September 9, 2006
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Cinta Mestre-Escorihuela, Fanny Rubio-Moscardo, Jose A Richter, et al.
Blood
|
September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Nature Medicine
|
June 12, 2012
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
Alex Kentsis, Casie Reed, Kim L Rice, et al.
The American Journal of Surgical Pathology
|
July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling
Ji Yuan, George Wright, Andreas Rosenwald, et al.
Blood Advances
|
September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Colleen A Ramsower, George Wright, Hongli Li, et al.
Blood
|
February 21, 2004
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
Lisa M Rimsza, Robin A Roberts, Thomas P Miller, et al.
Cancer Cell
|
June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma
Yibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Cancer Cell
|
May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
Jaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 286) with videos related to
Sort By:
Page
of 29
Blood
|
May 28, 2009
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
Ellen Leich, Itziar Salaverria, Silvia Bea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
David W Scott, Anja Mottok, Daisuke Ennishi, et al.
Blood
|
September 9, 2006
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Cinta Mestre-Escorihuela, Fanny Rubio-Moscardo, Jose A Richter, et al.
Blood
|
September 25, 2003
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Nature Medicine
|
June 12, 2012
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
Alex Kentsis, Casie Reed, Kim L Rice, et al.
The American Journal of Surgical Pathology
|
July 3, 2015
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling
Ji Yuan, George Wright, Andreas Rosenwald, et al.
Blood Advances
|
September 18, 2025
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma
Colleen A Ramsower, George Wright, Hongli Li, et al.
Blood
|
February 21, 2004
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
Lisa M Rimsza, Robin A Roberts, Thomas P Miller, et al.
Cancer Cell
|
June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma
Yibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Cancer Cell
|
May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
Jaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Page
of 29